What's New

Lorlatinib (Lorbrena®)

Lorlatinib (Lorbrena®) is a tyrosine kinase inhibitor (TKI) used in the treatment of progressive, metastatic non small cell lung cancer.

Talazoparib (Talzenna™)

Talazoparib (Talzenna™) is a PARP inhibitor used in the treatment of some types of breast cancer. 

Cemiplimab-rwlc (Libtayo®)

Cemiplimab-rwlc (Libtayo®) is a monoclonal antibody used in the treatment of some cases of squamous cell cancer of the skin. 


OncoLink's Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

Patient Education by the Numbers: Part I
by OncoLink Team
Nov 12, 2018

Affordable Care Act Open Enrollment: What You Need To Know For 2019
by Christina Bach, MSW, LCSW, OSW-C
Nov 1, 2018

View all Blogs

Lung Cancer Awareness Month

Visit our Lung Cancer section for more information about the types of lung cancer. The Lung Webucation webinar presents all you need to know after a new diagnosis. Dr. Vachani discusses lung cancer risk, prevention and the recommendations for lung cancer screening. Visit Donna Lee's blog for inspiration from a survivor. 

Need Cancer Patient Education Tools?

Our award winning cancer education content is now available for licensing and syndication.

I Wish U Knew!

I Wish U Knew is a video series featuring oncology professionals and survivors discussing what they wish patients and the public knew about cancer.